• Anunciar DOTmed's certificado parte o programa do vendedor: Os compradores qualificados ganham 1% em compras das peças. Estale aqui para mais. 
• sell $
• au sujet de
• My DOTmed 

CHICAGO, IL -- Today, GE Healthcare (NYSE: GE) launches two new ultrasound systems for the women's health market, the Voluson® E6 and LOGIQ® P3. Both systems are being showcased May 4-6, at the 57th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG), in Chicago at GE Healthcare's booth #1315.

The Voluson E6 is the entry-level system to the advanced E-Series Voluson platform, and is designed specifically for obstetric and gynecological clinical applications. Designed for the everyday user, Voluson E6 features new attributes to help clinicians achieve higher levels of image quality and efficiency. Innovations in automation for the fetal heart, a scan assistant for quality assurance and improved workflow, and new transducer technology are just a few of the key features in this product introduction.

According to Karl-Heinz Lumpi, General Manager, GE Healthcare Women's Health and Specialty Ultrasound, the Voluson E6 fulfills an important role in the Voluson E-Series product line. "The Voluson E6 is designed to address the needs of OB/GYN physicians who care for large patient populations and need to have a versatile system with reliable, high quality imaging. This is a system that can be a workhorse for an OB/GYN practice and has expandable capabilities that can grow to meet the future needs of a practice. " Lumpi said.

The LOGIQ P3 is an economical, compact console ultrasound system offering surprising performance that can help clinicians deliver advanced imaging to OB/GYN practices. GE Healthcare has migrated robust features sets as CrossXBeamTM from more advanced LOGIQ systems, which enables the LOGIQ P3 to provide excellent performance. The LOGIQ P3 feature set is well-suited for OB applications and the system is compatible with the most frequently used LOGIQ obstetric transducers. Its lightweight and ergonomic design is small enough to easily maneuver to exam rooms and its robust workflow capabilities also help clinicians meet emerging digital information requirements for healthcare providers.

Additional GE Healthcare ultrasound products showcased at ACOG include:

Voluson E8 Breakthrough 2009
The Voluson E8 Breakthrough 2009 includes innovative features that offer clinically relevant enhancements to help provide improved workflow efficiencies, outstanding image quality, increased automation and improved speed for advanced imaging applications. A significant architecture enhancement is the new Dynamic Rendering Engine which helps provide stunning next-generation 3D rendering. The harmonization between the Voluson platform, Dynamic Rendering Engine and advanced transducers helps clinicians achieve extraordinary image quality and seamless operation. This extensive Breakthrough provides a broad offering of new and enhanced tools that help clinicians stay on the forefront of women's healthcare and to better assess patients.

LOGIQ P5 and LOGIQ P6 Breakthrough 2009
Breakthrough 2009 for the LOGIQ P5 and LOGIQ P6 includes enhancements that help improve image quality, workflow and sonographer comfort. Continuing the tradition of migrating advanced feature sets throughout the GE ultrasound portfolio, both systems now benefit from Voluson image optimization algorithms that provide improved 3D image quality. Real-time 4D has also been optimized to an improved performance level. Other improvements include: new transducers that help provide improved image quality and patient comfort; a new hard drive for increased speed; expanded reporting packages; and an enhanced 17" monitor featuring new optical filters to help improve contrast resolution and reduce glare.


ABOUT GE HEALTHCARE

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.


A prior version of this story included the incorrect photograph. We apologize for the error.